RP Bio Inc. (KOSDAQ:314140)
South Korea
· Delayed Price · Currency is KRW 7,110.00
+60.00 (0.85%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2017 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '17 Dec 31, 2017 | 2019 |
| Health Functional Food | 71.86B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Health Functional Food Growth | -16.44% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medicines | 51.47B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Medicines Growth | -19.44% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Raw Materials, etc. | 332.92M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Raw Materials, etc. Growth | -63.46% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 303.20M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 19.92% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceuticals | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceuticals Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 303.20M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 19.92% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2017 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '17 Dec 31, 2017 | 2019 |
| Other | 1.38B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 128.34% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea | 122.59B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | -18.52% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 1.38B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 128.34% |
Log In |
Log In |
Log In |
Log In | Upgrade
|